GL1X · GenesisL1 explorer

Research workbench

Crystal structures of high affinity human T-cell receptors bound to pmhc revealnative diagonal binding geometry unbound TCR clone 5-1

Analyse Crystal structures of high affinity human T-cell receptors bound to pmhc… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2PYF
Type
protein
Length
446 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
T-cell receptor, alpha chain; T-cell receptor, beta chain
UniProt
Q6PIZ8, Q6NS87
Ligands
SO4
Pockets
5 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 7% helix, 49% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AT-cell receptor, alpha chainprotein2055% helix, 48% strandQ6PIZ8
BT-cell receptor, beta chainprotein2417% helix, 51% strandQ6NS87

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 6 copies · chains A, B
  • PGE · Triethylene glycol · additive · 4 copies · chains A, B
  • PG4 · Tetraethylene glycol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110890.730.7685PG4, SO4
2980.410.7722PGE
31030.380.7523empty
4950.340.7416empty
5540.320.7614empty

Interfaces

1 interface between chains.

  • A–B · 2359 Ų buried · 31 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 5 disulfide (disulfide).

Compared structures

  • 2PYF · Crystal Structures of High Affinity Human T-Cell Receptors Bound to pMHC RevealNative… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.